01—Abstract
Summary
Summary of the 10-K filed February 11, 2009. Cited figures are marked; the original filing is the authoritative source.
UnitedHealth Group Inc. (UNH) reported significant revenue growth of 8% to $81.2 billiona for the fiscal year ended December 31, 2008.
This growth was primarily driven by acquisitions and premium rate increases in its Health Care Services segment. However, net earnings decreased by 36% to $3.0 billionb, or $2.40 per diluted share, compared to 2007. This decline in profitability was attributed to higher operating costs, including significant settlement expenses related to historical stock option practices, and increased medical costs that outpaced premium rate adjustments in some areas.
The company actively pursued strategic acquisitions in 2008, including Sierra Health Services, Inc. and Fiserv Health, Inc., which expanded its market presence and service offerings. Despite a challenging economic environment and a 30%c decrease in diluted EPS, UNH maintained a strong balance sheet with significant cash and investments, demonstrating resilience. The company's diversified business model, encompassing health benefits and health services, positions it to navigate industry pressures and regulatory changes, though investors should monitor the impact of ongoing healthcare reform discussions and economic conditions on future performance.
02—Key points
Key Highlights
- Consolidated revenues increased by 8% to $81.2 billion in 2008, driven by acquisitions and premium rate increases.
- Net earnings decreased by 36% to $3.0 billion, or $2.40 per diluted share, primarily due to increased operating costs and settlements.
- The company completed several significant acquisitions in 2008, including Sierra Health Services and Fiserv Health, to expand its service offerings and market reach.
- Medical costs as a percentage of premium revenues (medical cost ratio) increased by 1.4% to 82.0% in 2008, indicating rising healthcare expenses outpacing premium growth in certain areas.
- Operating costs increased significantly in 2008, partly due to $882 million in expenses for proposed settlements of stock option practice lawsuits.
- Despite the profit decline, UnitedHealth Group maintained a strong liquidity position with $21.6 billion in cash, cash equivalents, and investments at year-end 2008.
- The company's stock price experienced significant volatility throughout 2008, reflecting broader market conditions and company-specific challenges, closing the year down 51% from its January peak.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2008, UnitedHealth Group Inc kept $0.04.
- Revenue$81.19B100.0%
- Cost of revenue−$1.48B1.8%
- Gross profit$79.71B98.2%
- Operating costs−$74.44B91.7%
- Operating income$5.26B6.5%
- Interest, other & tax−$2.29B2.8%
- Net income$2.98B3.7%
Where FY2008 revenue went
$81.19B- Other operating costs: $61.34B, 76% of revenue
- SG&A: $13.10B, 16% of revenue
- Net income: $2.98B, 3.7% of revenue
- Cost of revenue: $1.48B, 1.8% of revenue
- Interest, other & tax: $2.29B, 2.8% of revenue
Kept 3.7% as net incomeNet income $2.98B · 3.7%
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2008filed February 11, 2009Financial Statements
FY2008 against FY2007
| Line item | FY2008FY2007 | Change |
|---|---|---|
| Revenue | $81.19B$75.43B | +7.6% |
| Cost of Revenue | $1.48B$768.00M | +92.7% |
| Gross Profit | $79.71B$74.66B | +6.8% |
| SG&A Expenses | $13.10B$10.58B | +23.8% |
| Operating Expenses | $75.92B$67.58B | +12.3% |
| Operating Income | $5.26B$7.85B | −32.9% |
| Interest Expense | $639.00M$544.00M | +17.5% |
| Net Income | $2.98B$4.65B | −36.0% |
| EPS (Basic) | $2.45$3.55 | −31.0% |
| EPS (Diluted) | $2.40$3.42 | −29.8% |
| Shares Outstanding (Basic) | 1.21B1.31B | −7.5% |
| Shares Outstanding (Diluted) | 1.24B1.36B | −8.8% |
05—Questions
Frequently Asked Questions
What were the main drivers of UnitedHealth Group's revenue growth in 2008?
Revenue growth was primarily driven by acquisitions, notably Sierra Health Services and Fiserv Health, which expanded the company's service offerings and market presence. Additionally, premium rate increases, particularly in the Health Care Services segment, and growth in the number of individuals served by its Public and Senior Markets Group contributed to the increase.
Why did net earnings and earnings from operations decrease significantly in 2008?
Net earnings and earnings from operations saw a substantial decrease due to a combination of factors. These included higher medical costs that outpaced premium increases in some risk-based products, a significant increase in operating costs driven by large settlement expenses related to historical stock option practices ($882 million) and other litigation, and the impact of acquisitions on operating expenses before full integration and synergies were realized. The overall operating margin declined from 10.4% in 2007 to 6.5% in 2008.
What is the company's outlook regarding the impact of the economic downturn on its business?
The company noted that the recessionary economic environment impacted demand for certain products, leading to lower enrollment in employer-sponsored plans, though Medicaid participation increased. Management expects economic recessions to slow revenue growth and potentially impact operating profitability. Additionally, prolonged economic downturns could lead to reduced government funding for healthcare programs and negatively affect the financial position of healthcare providers, potentially increasing medical cost trends.
How is UnitedHealth Group managing its investment portfolio in the current market environment?
UnitedHealth Group maintained a highly liquid position with $21.6 billion in cash, cash equivalents, and investments as of December 31, 2008. The investment portfolio has a short average duration and a weighted average credit rating of 'AA'. The company actively manages its exposure by diversifying across market sectors and limiting investments to investment-grade securities. Given the significant portion held in cash equivalents and short-duration instruments, the company does not anticipate material impacts on liquidity from fair value fluctuations.
06—Continue